Cannabis now plays a more prominent role in mental health discussions. Once primarily recreational, it is now used and occasionally recommended for anxiety, sleep issues, and coping with trauma or depression. Experiences differ: some find relief, others notice no change, and some experience worsening symptoms. Acknowledging this diversity respects individual relationships with cannabis (Sarris et al., 2020).
At the same time, established therapies and supports such as cognitive behavioral therapy and other evidence-based approaches have consistently been shown to improve mental health outcomes. (The evidence for cognitive behavioral therapy in any condition, population, or environment: a meta-review of systematic reviews and panoramic meta-analysis, 2020, pp. 441-451). Knowing about these options can help people make more educated decisions concerning their care.
A broader review of the research reveals a more complex picture.
A large 2026 systematic review published in The Lancet Psychiatry found no reliable evidence supporting cannabis-based treatments for anxiety, depression, or PTSD (Wilson et al., 2026). Earlier large-scale reviews reported similar results: research on cannabis and mental health is limited and inconsistent (Black et al., 2019; Solmi et al., 2023; Hoch et al., 2025). Overall, the current evidence does not support cannabis as a consistent treatment for these conditions.
If you are considering cannabis for mental health, consult a health professional about your options and any personal or family risk factors. Ask about evidence-based therapies and supports, and track your well-being over time to assess whether cannabis use is beneficial. Combining personal experience with current evidence helps you make informed decisions. Many people continue to use cannabis and report benefits. These differing experiences can coexist.
Where the Confusion Starts
Some confusion arises from how cannabis is discussed. Current research does not support the claim that cannabidiol (CBD) has acute effects on brain responses to emotional processing or anxiety, as evidence indicates that CBD did not significantly influence brain activity related to emotional faces, cognitive measures of emotion, or experimentally induced anxiety compared to placebo (Bloomfield et al., 2022).
At first glance, it appears to be an effective treatment. However, biological changes in the brain do not always lead to meaningful or lasting symptom improvement. Early studies often focus on short-term effects in controlled settings. When those findings are tested in larger, more rigorous clinical trials involving people navigating real-life stress and complex histories, the results are far less consistent (Kansagara et al., 2026).
Relief Is Real, but Distinct from Lasting Change
Another source of confusion is that many people genuinely feel better when using cannabis. Cannabis can reduce immediate distress by lowering physiological arousal, calming racing thoughts, and creating distance from overwhelming emotions. For someone who feels constantly activated, that can feel like a reset (Sarris et al., 2020). Immediate relief differs from lasting change.
Mental health conditions are shaped by patterns. These include how your nervous system responds, how emotions are processed, and how experiences are stored over time (Duville et al., 2023). When something provides relief without shifting those patterns, it can become part of a cycle rather than a solution (Anderer, 2026).
Research shows that expectations influence outcomes. Beliefs about cannabis can shape how its effects are experienced, especially regarding anxiety and mood (Chen et al., 2025). This does not make the relief inauthentic; it indicates that multiple factors contribute to it.
What Does the Evidence Actually Suggest
Higher-quality studies show inconsistent evidence: some report short-term benefits for anxiety and sleep, but overall, there are no reliable long-term improvements in mental health.
Some smaller trials suggest cannabis may help with short-term anxiety and sleep issues, but variations in types, doses, participant groups, and measurement methods make results difficult to compare. Overall, the evidence is inconsistent and often low quality, making clear conclusions about cannabis’s mental health effects challenging (Perez et al., 2025, pp. 219-237).
However, clearer patterns emerge regarding risk.
Cannabis affects brain systems related to perception, memory, and reward. In some individuals, especially those already vulnerable, it can increase the likelihood of psychotic symptoms and contribute to dependence over time (Hoch et al., 2025; D’Souza et al., 2005).
Cannabis is not harmless or neutral for everyone
In recent years, as global regulatory changes have led to increased research into medicinal cannabis, individuals may find themselves considering not whether cannabis is inherently good or bad, but rather how to interpret and apply emerging information about its effects, particularly if they perceive it as helpful (Sarris et al., 2020).
A helpful way to approach this is to acknowledge both realities at once. Research suggests cannabis may not create lasting change on its own. Rather than choosing one perspective, it is more useful to remain curious. Is this helping me move forward or just helping me get through? What happens when I do not use it? Are things improving over time, such as sleep, mood, relationships, and functioning?
You do not need to stop using something that provides immediate relief, but ensure it is not replacing more effective options. If you seek alternatives for long-term mental health, consider evidence-based approaches. Therapy, such as cognitive behavioral therapy, addresses underlying patterns and builds lasting skills. Consistent sleep routines improve mood and resilience. Mindfulness practices, including meditation and breathing exercises, reduce stress and support emotional balance. Physical activity and creative outlets can also be beneficial. These strategies may offer more sustainable relief over time and can complement other supports.
What Actually Supports Long-Term Mental Health
If cannabis is not consistently supported as a primary treatment, the next question is what works better. For most people, long-term improvement comes from a combination of therapy targeting underlying patterns, skills to regulate the nervous system, consistent routines, especially around sleep, and medication when appropriate (Lau et al., 2025). These approaches do not just reduce distress in the moment. They help change how that distress manifests over time (Cooper et al., 2015), and this is where personalization matters.
Cannabis tends to carry more risk for people who have a personal or family history of psychosis, notice increased anxiety or paranoia when using, are using it frequently or in higher amounts, or rely on it as their primary way of coping (Steur et al., 2020). If you identify with any of these situations, it may be helpful to pause and reflect on your own patterns, or to talk with a trusted health professional. Considering your personal and family mental health history can support safer, more informed decisions about whether and how to use cannabis.
It may feel less disruptive for people who use it occasionally, do not experience negative side effects, and engage in other forms of support (Kansagara et al., 2026). Lower risk does not guarantee long-term benefit. The impact can still vary.
How Do You Know If It Is Becoming a Problem
Cannabis use often becomes less helpful gradually. Some patterns to pay attention to include needing more over time to get the same effect, feeling more anxious or foggy, difficulty cutting back, using it to avoid rather than cope, changes in memory or focus, and pulling away from responsibilities or relationships (Pilon et al., 2025). It is important to recognize that mental health decisions are rarely made under ideal conditions.
Access to effective care is still a major barrier. Cost, availability, and trust all influence whether someone engages in therapy or other treatments (Jiang et al., 2026). Despite these obstacles, people continue to show remarkable resilience and resourcefulness as they seek ways to feel better and support their well-being. Choosing to seek relief, whether through traditional or alternative approaches, is an act of courage.
Research continues to show that mental health outcomes are shaped by broader social and environmental factors rather than just individual symptoms (Cénat, 2026). In that context, recent evidence indicates that increased availability of medical cannabis did not have negative effects on mental health in the adult population overall (Drake et al., 2024). Cannabis offers immediate and accessible relief without the need to navigate complex systems.
Where This Leaves Us
The current evidence is clear: cannabis is not supported as a primary or reliable treatment for anxiety, depression, or PTSD. At the same time, many people experience relief when they use it. Both can be true. A more useful question is not whether cannabis is good or bad. Instead, consider what role it is playing. Is it supporting you in the short term? Or is it replacing something that could provide more lasting support? Mental health care is not just about reducing distress in the moment. It is about building the capacity to manage distress differently over time.
References
Anderer, S. (2026, March 26). Review of cannabis use finds insufficient evidence of mental health benefit. JAMA.
Black, N., Stockings, E., Campbell, G., Tran, L. T., Zagic, D., Hall, W. D., Farrell, M., & Degenhardt, L. (2019). Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis. The Lancet Psychiatry, 6(12), 995–1010.
Cénat, J. M. (2026). Anticipating psychiatric disorders without neglecting social determinants. The Lancet Psychiatry, 13(4), 286.
Chen, M. Y., Kramer, E. B., Gibson, L. P., et al. (2025). Investigating the relationship between cannabis expectancies and anxiety, depression, and pain responses after acute cannabis use. Cannabis and Cannabinoid Research, 10(1), 71–80.
Cooper, K., Chatters, R., Kaltenthaler, E., & Wong, R. (2015). Psychological and psychosocial interventions for cannabis cessation in adults: A systematic review. Health Technology Assessment.
Cuijpers, P., Harrer, M., Miguel, C., et al. (2025). Cognitive behavioral therapy for mental disorders in adults: A unified series of meta-analyses. JAMA Psychiatry, 82(6), 563–571.
de Almeida, D. L., & Devi, L. A. (2020). Diversity of molecular targets and signaling pathways for CBD. Pharmacology Research & Perspectives, 8(3), e00682.
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., et al. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry, 57(6), 594–608.
Duville, M. M., Pérez, Y., Hugues-Gudiño, R., Naal-Ruiz, N. E., Alonso-Valerdi, L. M., & Ibarra-Zárate, D. I. (2023). Emotion recognition based on electrophysiological patterns for emotion regulation detection: A systematic review. Applied Sciences, 13(12).
Hoch, E., Volkow, N. D., Friemel, C. M., et al. (2025). Cannabis, cannabinoids, and health: A review of evidence. European Archives of Psychiatry and Clinical Neuroscience, 275(2), 281–292.
Jiang, Y., Lin, K., Dalton, H., Buys, N., & Sun, J. (2026). Assessment of barriers to accessing mental health services in rural or remote areas using a socio-ecological resilience framework: A scoping review. International Journal of Mental Health Systems, 20.
Kansagara, D., Terry, G. E., Ayers, C. K., & D’Souza, D. C. (2026). Cannabis and mental health: A review. JAMA Internal Medicine.
Lau, S. C., Tipton, J., Kebrdle, K., Wang, H., Levy, A., Hardi, A., Tang, W. K., Harvey, A. G., & Skidmore, E. R. (2025). Non-pharmacological insomnia interventions for improving sleep and mood in people with neurological disorders: A systematic review and meta-analysis. Sleep.
Melas, P. A., Scherma, M., Fratta, W., et al. (2021). Cannabidiol as a potential treatment for anxiety and mood disorders: Molecular targets and epigenetic insights. International Journal of Molecular Sciences, 22(4), 1863.
Pilon, F., Dumais, A., Giguère, C., & Potvin, S. (2025). The effects of cannabis use disorder on cognitive functions: A meta-analysis. Addictive Behaviors, 170.
Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: A clinically focused systematic review. BMC Psychiatry, 20.
Solmi, M., De Toffol, M., Kim, J. Y., et al. (2023). Balancing the risks and benefits of cannabis use: An umbrella review. BMJ, 382, e072348.
Steur, S. J., Batalla, A., & Bossong, M. G. (2020). Factors moderating the association between cannabis use and psychosis risk: A systematic review. Brain Sciences, 10(2).
Wilson, J., Dobson, O., Langcake, A., et al. (2026). The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: A systematic review and meta-analysis. The Lancet Psychiatry.






